acamprosate has been researched along with Genetic Predisposition in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abulseoud, OA; Biernacka, JM; Choi, DS; Cunningham, JM; Frank, J; Frye, MA; Geske, JR; Hall-Flavin, DK; Jenkins, GD; Karpyak, VM; Kiefer, F; Kononenko, O; Leontovich, AA; Loukianova, LL; Mann, KF; Nöthen, MM; Rietschel, M; Rüegg, J; Schneekloth, TD; Skime, MK; Weinshilboum, RM | 1 |
| Cwiek, W; Czarnecka, E; Dyr, W; Zalewska-Kaszubska, J | 1 |
| Diehl, A; Jiménez-Arriero, MA; Kiefer, F; Klein, O; Rubio, G | 1 |
3 other study(ies) available for acamprosate and Genetic Predisposition
| Article | Year |
|---|---|
Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.
Topics: Acamprosate; Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Deterrents; Alcoholism; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Remission Induction; Taurine; Time Factors; Treatment Outcome; Young Adult | 2014 |
Changes in the beta-endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; beta-Endorphin; Brain; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Ethanol; Female; Genetic Predisposition to Disease; Opioid Peptides; Rats; Taurine; Treatment Outcome; Up-Regulation | 2005 |
Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Spain; Taurine; Treatment Outcome | 2008 |